Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
Vir Biotechnology is looking for a Senior Accountant to play a critical role in our monthly and quarterly close processes. You will own complex accruals and balance sheet areas, partner cross‑functionally to resolve issues, and help ensure the accuracy and integrity of our financial reporting in a SOX‑compliant environment. This is a hands‑on role with meaningful ownership, ideal for someone who enjoys digging into the details while continuously improving close processes.
This role reports to the Sr. Director, Accounting Operations and is located in our San Francisco headquarters with an expectation of 3 days per week in office.
WHAT YOU'LL DO- Own the preparation and review of monthly and quarterly journal entries, including G&A accruals (legal, professional services, facilities, software subscriptions), cash and investments, depreciation, amortization, and prepaid expense activity
- Manage balance sheet reconciliations for assigned areas such as cash and investments, prepaids, fixed assets, and accrued G&A services, investigating variances and resolving issues
- Maintain and review prepaid amortization schedules in FloQast, including short‑term and long‑term classifications and review for unpaid prepaid adjustments
- Support PO‑based accruals across G&A, facilities, subscriptions, and PP&E categories, ensuring accurate period‑end cut‑off
- Prepare fixed assets rollforward
- Provide Accounts Payable coverage as needed, including invoice processing, Coupa review for accruals, and AP accrual support during close
- Support SOX controls and audits by preparing documentation, tie‑outs, and responding to internal and external audit requests
- Compile and review monthly headcount reporting and serve as a key point of contact for your assigned close areas
- Identify opportunities to improve close efficiency, documentation, and processes
- Bachelor’s degree in Accounting or Finance (CPA a plus)
- 5+ years of progressive accounting experience, including month‑end and quarter‑end close in a SOX environment
- Strong knowledge of accrual accounting, prepaids, fixed assets, and P&L analysis
- Proven ability to independently own close areas, investigate discrepancies, and exercise sound judgment
- Experience with NetSuite, Coupa, and FloQast (preferred)
- Advanced Excel skills, including pivot tables, lookups, and structured schedules
The expected salary range for this position is $104,500 to $145,500 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
Skills Required
- Bachelor's degree in Accounting or Finance
- 5+ years of progressive accounting experience
- Strong knowledge of accrual accounting and P&L analysis
- Experience with NetSuite, Coupa, and FloQast
- Advanced Excel skills, including pivot tables and lookups
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world. We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™. Join us as we pursue our mission to transform lives. It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
